“There is Desperate Need for New Drug Targets”

The Silicon Valley/San Jose Business Journal recently covered the Myelin Repair Foundation, giving an outline of our ARC research model and our goals.

Scott Johnson

Scott Johnson, Founder and President of the MRF & MS patient

Quote:

Johnson and his initial advisory team set out to narrowly define what is the most significant way to impact MS in the shortest period of time, and that was myelin repair. They invited five principal investigators to a meeting and said, “We want to fund you but we will only do it if we put together a plan and you collaborate completely.”

Share and Enjoy:
  • Print
  • Digg
  • Sphinn
  • del.icio.us
  • Facebook
  • Mixx
  • Google Bookmarks
  • MySpace
  • StumbleUpon
  • Yahoo! Bookmarks

1 Comment »

  1. Up to date information, is there any personal etail or contact available and perhalps personal contact.

    Regards
    Malcolm Gibb
    m4lcg@btinternet.com
    Tel: 07765870626

    Comment by Malcolm Gibb — October 25, 2009 @ 4:41 am

RSS feed for comments on this post. TrackBack URL

Leave a comment